The Association of Glucose Metabolism Disorders and Acne in Women With Polycystic Ovary Syndrome (PCOS)
Abstract
BACKGROUND/AIM: Acne is a common dermatological manifestation of polycystic ovary syndrome (PCOS), a prevalent endocrinological disorder among women of reproductive age. A growing body of evidence highlights glucose metabolism disorders, including insulin resistance, in the context of PCOS. This study aimed to investigate the association of acne and its severity with insulin resistance in a population of women with PCOS.
PATIENTS AND METHODS: A total of 305 women with PCOS aged between 17-35 years were included in this retrospective observational study. Anthropometric, hormonal, biochemical, and ultrasonographic markers of PCOS were analyzed in relation to insulin resistance indices, including HOMA-IR and QUICKI.
RESULTS: Acne was present in 56.4% of participants, with 52.1% exhibiting mild and 4.3% severe cases. Younger age (p=0.006), higher DHEAS levels (p=0.001), and glucose metabolism disorders, including fasting glucose >100 mg/dl, p=0.026 and 2-h glucose higher than 140 mg/dl (p=0.019), were significantly associated with acne. Multivariate analysis indicated younger age (OR=0.94, p=0.012), elevated DHEAS levels (OR=1.03; p=0.006), and 2-h glucose levels >140 mg/dl (OR=3.25, p=0.029) as independent predictors of acne severity.
CONCLUSION: This study indicates the association between insulin resistance and hyperandrogonemia with both the presence and severity of acne in PCOS. These findings align with contemporary literature and underscore the importance of addressing…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 305 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.